Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors
MedPage Today) -- The FDA approved marstacimab (Hympavzi) for routine prophylaxis to prevent or reduce bleeding episodes in adults and...
Margarete Grisby
MedPage Today) -- The FDA approved marstacimab (Hympavzi) for routine prophylaxis to prevent or reduce bleeding episodes in adults and...
